SC
IMGN

Steven Cohen’s Immunogen Inc IMGN Stock Holding History

Steven Cohen’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,712,142
Closed -$164M – 2978
2023
Q2 		$164M Buy
+8,712,142
New +$103M 0.49% 34
2022
Q2 		– Sell
-432,678
Closed -$2.06M – 1707
2022
Q1 		$2.06M Buy
+432,678
New +$2.4M 0.01% 869
2021
Q4 		– Sell
-714,700
Closed -$4.05M – 1367
2021
Q3 		$4.05M Buy
+714,700
New +$4.13M 0.02% 697
2019
Q1 		– Sell
-2,654,299
Closed -$11.5M – 1286
2018
Q4 		$12.7M Sell
2,654,299
-3,518,466
-57% -$21.3M 0.06% 361
2018
Q3 		$58.5M Buy
6,172,765
+4,116,832
+200% +$39.6M 0.24% 111
2018
Q2 		$20M Buy
+2,055,933
New +$21.7M 0.08% 303

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steven Cohen's IMGN Position: Q3 2023 in Review

Steven Cohen sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 8,712,142 shares — an estimated $164M sold.

Steven Cohen first reported a position in IMGN in Q2 2018 and held it in 6 quarters. The position peaked at $164M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Steven Cohen reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Steven Cohen sold 8,712,142 Immunogen Inc shares in Q3 2023, an estimated $164M.
  • Steven Cohen first reported a position in Immunogen Inc in Q2 2018 and held it in 6 quarters.
  • Steven Cohen's Immunogen Inc position peaked at $164M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.